BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li PP, Li RG, Huang YQ, Lu JP, Zhang WJ, Wang ZY. LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability. Aging (Albany NY) 2021;13:24171-91. [PMID: 34740994 DOI: 10.18632/aging.203672] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Zhang J, Yan X, Xie P, Fu Y, Fu X, Sun X, Han D, Li S, Zheng Y, Gao Y, Kim N, Yuan B, Jiang H. DNA Double-Strand Break-Related Competitive Endogenous RNA Network of Noncoding RNA in Bovine Cumulus Cells. Genes 2023;14:290. [DOI: 10.3390/genes14020290] [Reference Citation Analysis]
2 吕 敏. Application of Targeted Autophagy in Triple Negative Breast Cancer. ACM 2023;13:62-67. [DOI: 10.12677/acm.2023.131010] [Reference Citation Analysis]
3 Heng Jiang, Xu Zhang, Xin Li, Xiaocen Wang, Nan Zhang, Pengtao Gong, Xichen Zhang, Yanhui Yu, Jianhua Li. Cryptosporidium parvum regulates HCT-8 cell autophagy to facilitate survival via inhibiting miR-26a and promoting miR-30a expression. Parasit Vectors 2022;15:470. [PMID: 36522638 DOI: 10.1186/s13071-022-05606-y] [Reference Citation Analysis]
4 Chen J, Li X, Yan S, Li J, Zhou Y, Wu M, Ding J, Yang J, Yuan Y, Zhu Y, Wu W. An autophagy-related long non-coding RNA prognostic model and related immune research for female breast cancer. Front Oncol 2022;12:929240. [PMID: 36591508 DOI: 10.3389/fonc.2022.929240] [Reference Citation Analysis]
5 Luo Y, Tang W, Xiang S, Feng J, Zu X. Non-coding RNAs in breast cancer: Implications for programmed cell death. Cancer Letters 2022;550:215929. [DOI: 10.1016/j.canlet.2022.215929] [Reference Citation Analysis]
6 Li J, Kang J, Liu W, Liu J, Pan G, Mao A, Zhang Q, Lu J, Ding J, Li H. Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel <em>via</em> targeting miR-200b-3p/Bcl-2 axis. Eur J Histochem 2022;66. [DOI: 10.4081/ejh.2022.3529] [Reference Citation Analysis]
7 Freiesleben S, Unverricht-yeboah M, Gütebier L, Waltemath D, Kriehuber R, Wolkenhauer O. A workflow for the creation of regulatory networks integrating miRNAs and lncRNAs associated with exposure to ionizing radiation using open source data and tools. Front Syst Biol 2022;2. [DOI: 10.3389/fsysb.2022.928159] [Reference Citation Analysis]
8 Zhang L, Ye B, Chen Z, Chen Z. Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.10.002] [Reference Citation Analysis]
9 Lv W, Tan Y, Zhou X, Zhang Q, Zhang J, Wu Y. Landscape of prognosis and immunotherapy responsiveness under tumor glycosylation-related lncRNA patterns in breast cancer. Front Immunol 2022;13:989928. [DOI: 10.3389/fimmu.2022.989928] [Reference Citation Analysis]
10 Eptaminitaki GC, Stellas D, Bonavida B, Baritaki S. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability. Drug Resistance Updates 2022;65:100866. [DOI: 10.1016/j.drup.2022.100866] [Reference Citation Analysis]
11 Entezari M, Taheriazam A, Orouei S, Fallah S, Sanaei A, Hejazi ES, Kakavand A, Rezaei S, Heidari H, Behroozaghdam M, Daneshi S, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomed Pharmacother 2022;154:113609. [PMID: 36037786 DOI: 10.1016/j.biopha.2022.113609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Han X, Mo J, Yang Y, Wang Y, Lu H. Crucial Roles of LncRNAs-Mediated Autophagy in Breast Cancer. Int J Med Sci 2022;19:1082-92. [PMID: 35813295 DOI: 10.7150/ijms.72621] [Reference Citation Analysis]
13 Singh D, Assaraf YG, Gacche RN. Long Non-coding RNA Mediated Drug Resistance in Breast Cancer. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Shi GJ, Zhou Q, Zhu Q, Wang L, Jiang GQ. A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs. J Clin Lab Anal 2022;:e24384. [PMID: 35441740 DOI: 10.1002/jcla.24384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]